Turkish Journal of Medical Sciences Published Study Results: Cadaver Vs Simulator Based Arthroscopic Training in Shoulder Surgery

February 9, 2021

Turkish Journal of Medical Sciences Key study findings show 20% faster procedure time for simulation training, 30% less cartilage damage during simulation training, VR Simulators as effective as “gold standard” cadavers for training arthroscopic procedures.

It is estimated that 20,000 people a year in the US donate their bodies (cadavers) for scientific and medical training purposes. This has dramatically changed during COVID-19, with these types of training often canceled, understandably due to the constraints imposed to control the spread of the virus. Even before the pandemic, each cadaver has limited use for medical training, and cadaveric training is not permitted in many other countries, there is vast potential for the growth in technology for training.

Simulation training has been able to continue throughout the pandemic, and forecasts predict that there will be a further shift towards virtual and mixed reality simulators. The findings of a recent study strengthen the evidence base for medical establishments to rapidly transition to digital training solutions and furthermore strengthens the outlook for simulation training in a post-COVID future.

Modern simulators are so advanced that they can realistically simulate the key elements needed to teach a surgical procedure including representing the physical anatomy for joint manipulation and palpation, and on-demand pathologies and complications. This way physicians can repeat their training cases ad infinitum until proficiency. In addition, simulators provide quantitative and visual feedback on damage, which is not possible with cadavers.

The recent study led by Dr. Gazi Huri, the Turkish Academy of Science, Young Scientist Award Winner has highlighted the benefits of simulation training during arthroscopic shoulder surgery. Trainees, undertaking the European Orthopaedics & Traumatology Education Platform accredited Shoulder Club International Cadaver Course, performed surgery on either donated cadavers or the VirtaMed ArthroS™ simulator. The results showed that course completion was 20% quicker and that cartilage showed significantly less damage (30%) when students trained, via simulation, proving that simulator training is a competent training technology for now and the future.

In the case of the Shoulder Club International Cadaver Course, VirtaMed simulators provided trainees with visual feedback on damage caused to shoulder cartilage. Trainees were, therefore, more aware and able to adjust and improve their techniques accordingly. As a result, there was 50% more damage caused to the cartilage by residents that had only used cadaveric training.

Can simulators be the replacement for cadavers in the future? With cadaver dissections still being seen as the golden standard for surgical training, their disadvantages have been highlighted during the pandemic – lack of replicability, lack of objective training metrics, and of course the potential safety issues of close contact training.

During 2020 and into this year, simulation training continued due to its flexibility and the ability to train with added safety measures in place. The aim of this study was to research the efficiency of using medical simulators in surgical training as a replacement for cadavers. The results showed that all students, both the cadaver and simulation groups, achieved the proficiency levels required to be competent in arthroscopic shoulder surgery, yet there were further positive outcomes from those training on the ArthoS™ simulator.

Dr. Gazi Huri, Associate Professor of Orthopedics and Traumatology at Hacettepe University said, “It is obvious that precautions taken for the Covid-19 pandemic would last for a long time. This circumstance highlights the importance of less crowded, individualized educational models in the medical field. For the fields such as orthopedics where practical training and hands-on education are an essential part, Virtual Reality Simulators can be considered as the best solution.

Huri added, “As far as we know this is the first time a study of this sort has been undertaken.  With the shift to VR simulators rapidly increasing in the medical training for several procedures, we wanted to demonstrate that the shift is beneficial to the industry. According to this study, we are able to state that VR Simulators are just as effective as cadavers for training arthroscopic procedures.”

Beat Rechsteiner, Senior Director International Business at VirtaMed, commented, “Our ArthroS™ simulator is used for training throughout the world and we are convinced that it is an essential training solution, particularly under the constraints of COVID-19.  This study demonstrates that now is the time to invest in simulator training and benefit from training residents quicker, safer, and with advanced proficiency.”

Read the full study here.

SourceVirtaMed

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.